Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer

Conclusion: ACT decreased the recurrence rate and distant metastasis rate thus improving prognosis for poorly differentiated or undifferentiated stage IIA colon cancer.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Qi Liu, Dakui Luo, Hongyin An, Sheng Zhang, Sanjun Cai, Qingguo Li, Xinxiang Li Tags: Research Paper Source Type: research